Skip to content
Thursday, October 8, 2026
Bingora Plus

Social Media Influencers Fueling Unofficial Market for Unapproved Weight-Loss Medication

A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to individuals injecting substances of uncertain source.

Some experts stated the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the service has taken down violative content and prohibited related hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at home.

Within moments of joining one community, a vendor posted contact information, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages display black plastic parcels with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service said it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake injections are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered patients injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to possibly significant medical dangers”.

JH
Written by

John Hernandez

Elara Vance is a UK-based interior design enthusiast and DIY blogger, sharing practical home improvement tips and creative decor ideas.

Bingora Plus

Type to search articles.